Effects of metoprolol and carvedilol on pre‐existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

BACKGROUND: β Blocker treatment may worsen glucose metabolism. OBJECTIVE: To study the development of new onset diabetes in a large cohort of patients with heart failure treated with either metoprolol or carvedilol. DESIGN: Prospective and retrospective analysis of a controlled clinical trial. SETTI...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Torp‐Pedersen, Christian, Metra, Marco, Charlesworth, Andrew, Spark, Phillip, Lukas, Mary Ann, Poole‐Wilson, Philip A, Swedberg, Karl, Cleland, John G F, Lenarda, Andrea Di, Remme, Willem J, Scherhag, Armin
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2007
Matèries:
Diabetes, Lipids and Metabolism
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1994413/
https://ncbi.nlm.nih.gov/pubmed/17237130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.092379
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars